QUART BARRY D sold 35.5% of their position (6.90K shares) of KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC on the open market
Open‑market sale worth $345.1K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/8/2026ACC: 0001384243-26-000008
Director
Since Feb 2026
-6.90K
Net shares
Net seller
$345.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.90K acquired · 13.80K disposed
Non-Derivative Transactions2
Class A Ordinary Share
Direct
Shares
+6.90K
Price / share
$14.33
Trade value
$98.89K
% of position
55.0%
4/6/2026
12.55K→19.45K
Class A Ordinary Share
Direct
Shares
−6.90K
Price / share
$50.00
Trade value
$345.05K
% of position
35.5%
4/6/2026
19.45K→12.55K
Total
Net shares
+0.00
Net value
-$246.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Share Direct | 4/6/2026 | M · Option Exercise | +6.90K | $14.33 | $98.89K | 55.0% | 12.55K | 19.45K |
| Class A Ordinary Share Direct | 4/6/2026 | S · Sale | −6.90K | $50.00 | $345.05K | 35.5% | 19.45K | 12.55K |
| Total | +0.00 | -$246.16K | ||||||
Derivative Transactions1
Share Option
Direct
Converts to
Class A Ordinary Shares
6.90K shares
Shares
−6.90K
Strike price
14.33
Held after
26.34K
Exercisable
—
4/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Share Option Direct | Class A Ordinary Shares6.90K shares | 4/6/2026 | M · Option Exercise | −6.90K | 14.33 | — | 26.34K |